Clinical Research Directory
Browse clinical research sites, groups, and studies.
Clinical Evaluation of the RH210 Hearing Aid
Sponsor: Rehear Audiology Company LTD
Summary
The RH210A is an air-conduction hearing aid designed for adults with perceived mild-to-moderate sensorineural hearing loss. The purpose of this clinical investigation is to generate objective and subjective evidence of the clinical performance and safety of the device.
Official title: Clinical Evaluation of the RH210 Hearing Aid Software Used With RH210A Device in Adults With Perceived Mild-to-Moderate Hearing Loss
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
24
Start Date
2026-04-11
Completion Date
2026-08-30
Last Updated
2026-05-29
Healthy Volunteers
No
Interventions
Investigational device (RH210A)
Over the counter device
Apple AirPods Pro (2nd Generation) with Hearing Aid Feature (HAF)
FDA cleared OTC device (Control arm)
Locations (1)
National Acoustic Laboratories
Macquarie Park, New South Wales, Australia